✦ LIBER ✦

Appearance of bone marrow lymphocytosis predicts an optimal response to imatinib therapy in patients with chronic myeloid leukemia

✍ Scribed by Mustjoki, S; Lundán, T; Knuutila, S; Porkka, K

Book ID: 110058317
Publisher: Nature Publishing Group
Year: 2007
Tongue: English
Weight: 225 KB
Volume: 21
Category: Article
ISSN: 0887-6924
DOI: 10.1038/sj.leu.2404807

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Effects of imatinib mesylate on normal b

Effects of imatinib mesylate on normal bone marrow cells from chronic myeloid leukemia patients in complete cytogenetic response

✍ Fermin M. Sanchez-Guijo; Jesus M. Hernandez; Eva Lumbreras; Patricia Morais; Car 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 418 KB

Imatinib Mesylate Therapy in Patients of

Imatinib Mesylate Therapy in Patients of Chronic Myeloid Leukemia with Philadelphia Chromosome Positive: An Experience from Eastern India

✍ A. Mukhopadhyay; S. Dasgupta; S. Mukhopadhyay; C. K. Bose; S. Sarkar; F. Gharami 📂 Article 📅 2011 🏛 Springer-Verlag 🌐 English ⚖ 195 KB

Imatinib trough plasma levels do not cor

Imatinib trough plasma levels do not correlate with the response to therapy in patients with chronic myeloid leukemia in routine clinical setting

✍ Edgar Faber; David Friedecký; Kateřina Mičová; Šárka Rožmanová; Martina Divoká; 📂 Article 📅 2012 🏛 Springer 🌐 English ⚖ 227 KB

Philadelphia-negative clonal hematopoies

Philadelphia-negative clonal hematopoiesis following imatinib therapy in patients with chronic myeloid leukemia: a report of nine cases and analysis of predictive factors

✍ Yulia Lin; Hélène Bruyère; Douglas E. Horsman; Tapio Pantzar; Michael J. Barnett 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 165 KB

Perturbation in the ability of bone marr

Perturbation in the ability of bone marrow stroma from patients with acute myeloid leukemia but not chronic myeloid leukemia to support normal early hematopoietic progenitor cells

✍ Rosemary L. Sparrow; Elizabeth O'Flaherty; Tania M. Blanksby; Jeffrey Szer; Mart 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 835 KB

Front-Line Therapy With Second-Generatio

Front-Line Therapy With Second-Generation Tyrosine Kinase Inhibitors in Patients With Early Chronic Phase Chronic Myeloid Leukemia: What Is the Optimal Response?

✍ Jabbour, E.; Kantarjian, H. M.; O'Brien, S.; Shan, J.; Quintas-Cardama, A.; Garc 📂 Article 📅 2011 🏛 American Society of Clinical Oncology 🌐 English ⚖ 126 KB